INCYTE

incyte-logo

Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs. Incyte's product pipeline is currently focused on oncology and inflammation and includes compounds in various stages of development. Through partnerships with [Novartis](/organization/novartis), [Eli Lilly](/organization/eli-lilly), and [Pfizer](/organization/pfizer), Incyte intends to promote the clinical development and global commercialization of several of their compounds.

#SimilarOrganizations #People #Financial #Website #More

INCYTE

Social Links:

Industry:
Biotechnology Medical Medical Device Pharmaceutical

Founded:
1991-01-01

Address:
Wilmington, Delaware, United States

Country:
United States

Website Url:
http://www.incyte.com

Total Employee:
501+

Status:
Active

Contact:
855-463-3463

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving


Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

brizzey-logo

Brizzey

Brizzey is a firm of seasoned professionals, which guides and supports companies in planning, production, global distribution.

nuchem-sciences-logo

NuChem Sciences

NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.

pantheryx-logo

PanTheryx

PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.

paxvax-logo

PaxVax

PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.

pci-pharma-services-logo

PCI Pharma Services

PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.

promiliad-biopharma-logo

Promiliad Biopharma

Promiliad Biopharma is an innovative drug discovery company that creates novel natural product-like small molecules.

tarsa-therapeutics-logo

Tarsa Therapeutics

Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.


Current Advisors List

wendy-dixon_image

Wendy Dixon Member of the Board of Directors @ Incyte
Board_member

jean-jacques-bienaime_image

Jean-Jacques Bienaime Board Member @ Incyte
Board_member
2015-01-01

not_available_image

Julian Baker Director, Member of Compensation Committee @ Incyte
Board_member
2001-01-01

Current Employees Featured

susan-snodgrass_image

Susan Snodgrass
Susan Snodgrass Vice President @ Incyte
Vice President
2020-02-01

elizabeth-oubre_image

Elizabeth Oubre
Elizabeth Oubre Director, Marketing Operations @ Incyte
Director, Marketing Operations
2013-08-01

not_available_image

Evan Cimino
Evan Cimino Research Scientist @ Incyte
Research Scientist
2017-08-01

jim-lee_image

Jim Lee
Jim Lee Group Vice President, Head Inflammation and AutoImmunity Group @ Incyte
Group Vice President, Head Inflammation and AutoImmunity Group
2018-12-01

nathalie-mueller-andriamboavonjy_image

Nathalie Mueller-Andriamboavonjy
Nathalie Mueller-Andriamboavonjy Senior Manager, Regulatory Affairs Operations @ Incyte
Senior Manager, Regulatory Affairs Operations

not_available_image

Tera Farhat
Tera Farhat Recruiting Consultat Incyte @ Incyte
Recruiting Consultat Incyte
2017-11-01

Founder


randy-scott_image

Randy Scott

Stock Details


Company's stock symbol is NASDAQ:INCY

Acquisitions List

Date Company Article Price
2016-05-09 ARIAD Pharmaceuticals - European operations ARIAD Pharmaceuticals - European operations acquired by Incyte 275 M USD
2003-02-18 Maxia Pharmaceuticals Maxia Pharmaceuticals acquired by Incyte N/A
2000-12-01 Proteome Proteome acquired by Incyte N/A
1998-01-22 Synteni Synteni acquired by Incyte N/A

Investments List

Date Company Article Money raised
2017-02-14 Agenus Incyte investment in Post-IPO Equity - Agenus 60 M USD
2002-03-27 Iconix Biosciences Incyte investment in Venture Round - Iconix Biosciences 20 M USD
2001-07-26 De Novo Pharmaceuticals Incyte investment in Series B - De Novo Pharmaceuticals 16.75 M GBP
2000-06-26 GeneEd Incyte investment in Seed Round - GeneEd 2 M USD

Official Site Inspections

http://www.incyte.com Semrush global rank: 494.63 K Semrush visits lastest month: 101.15 K

  • Host name: 20.119.8.32
  • IP address: 20.119.8.32
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Incyte"

Incyte - Wikipedia

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. [2] The company currently operates manufacturing and R&D locations …See details»

Incyte Biosciences CANADA - Biopharmaceutical …

Incyte Biosciences CANADA Incyte is a global biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. World-class science and R&D drive Incyte’s business and its …See details»

Incyte: A Global Biopharmaceutical Company on a …

Oct 19, 2023 Incyte is a global biopharmaceutical company using science to help address patients’ unmet needs. Focusing on patients and innovation and leveraging 2,400 employees and more than 1,000 world-class scientists, …See details»

Incyte - Crunchbase Company Profile & Funding

Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs.See details»

Investors | Incyte

Jun 15, 2025 The Investor Relations website contains information about Incyte's business for stockholders, potential investors, and financial analysts.See details»

Incyte Corporation Careers

Incyte prefers to recruit candidates directly rather than through a third-party recruiter or agency. Incyte will only pay a fee for candidates submitted or presented where there is a signed …See details»

Incyte - bioforward.org

Incyte’s unique expertise in medicinal chemistry and biology has enabled us to establish a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology …See details»

Incyte Leadership | Incyte.com

Prior to Incyte, Mr. Trotta served as the Head of Novartis U.S. Immunology, where he led a 400-person organization across dermatology, rheumatology, auto-inflammatory rare diseases and allergy. He additionally held leadership roles …See details»

Solutions for Unmet Medical Needs - Incyte

Incyte is a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.See details»

Global Biopharmaceutical Company | Incyte

Incyte is a global biopharmaceutical company that has created a robust and diversified portfolio of marketed products and clinical candidates in oncology, inflammation, and autoimmunity.See details»

Company Profile for Incyte Corporation | Incyte

Nov 07, 2003 -- Incyte is a drug discovery company that is using its expertise in genomics, medicinal chemistry and molecular, cellular and in vivo biology to discover and develop novel …See details»

Global Biopharmaceutical Company | Incyte.com

Incyte is a global biopharmaceutical company that has created a robust and diversified portfolio of marketed products and clinical candidates in oncology and inflammation and autoimmunity.See details»

Incyte: A biopharmaceutical company with brains and heart

Feb 11, 2022 With headquarters in Wilmington, Delaware, and offices worldwide, the biopharmaceutical company Incyte, offers plenty of professional and personal growth …See details»

Incyte Appoints Bill Meury Chief Executive Officer; Hervé …

5 days ago - Three-decade industry leader, former CEO of Karuna and Anthos and Chief Commercial Officer of Allergan, Bill Meury , joins Incyte as President and CEO - Hervé …See details»

From A Small Team of Research Scientists, Chemists ... - incyte.com

Read the story of how Incyte was started 20 years ago by a small team working in immunology and willing to tackle difficult medical problems.See details»

Global Responsibility - Incyte.com

Read Incyte’s responsibility statement explaining how they aim to operate their business in a way that builds trust, protects the environment and enhances communities.See details»

Incyte Corporation

Incyte Corporation is a biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. For additional information on Incyte, please visit …See details»

Incyte's CEO transition raises M&A hopes - fiercepharma.com

4 days ago After over a decade spent building Incyte up into a competitive commercial drugmaker, the company’s longtime CEO Hervé Hoppenot is making his exit and passing the …See details»

Incyte Stock Pops As New CEO Appointment Stokes M&A …

4 days ago Incyte stock popped Thursday after the company's board appointed Bill Meury as its new CEO, replacing Herve Hoppenot, who is retiring.See details»

Incyte Appoints Bill Meury Chief Executive Officer; Hervé …

5 days ago - Three-decade industry leader, former CEO of Karuna and Anthos and Chief Commercial Officer of Allergan, Bill Meury, joins Incyte as President and CEO - Hervé …See details»

linkstock.net © 2022. All rights reserved